June 25, 2016
Recommended Topic Related To:

OptiMARK

"The cystic fibrosis (CF) drug Orkambi (Vertex Pharmaceuticals) has received a green light from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP).

Orkambi is a fixed-dose oral combination "...

A A A

OptiMARK




Overdosage
Contraindications

OVERDOSE

Clinical consequences of overdosage with OptiMARK have not been reported. Treatment of overdose is directed toward supporting vital functions and prompt institution of symptomatic therapy. OptiMARK has been shown to be dialyzable [see CLINICAL PHARMACOLOGY].

CONTRAINDICATIONS

OptiMARK is contraindicated in patients with:

  • chronic, severe kidney disease (glomerular filtration rate, GFR < 30 mL/min/1.73m²)
  • acute kidney injury
  • known hypersensitivity reactions to gadolinium, versetamide or any of the inert ingredients.
This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 12/15/2014

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.